Major companies operating in the psychedelic mushroom market includes:
Compass Pathways
MindMed
Field Trip Health
Atai Life Sciences
Cybin Inc.
Mydecine Innovations Group
Revive Therapeutics
Numinus Wellness
Authors:
Kunal Ahuja, Himanshu Kabra
Frequently Asked Questions (FAQ) :
The market size of psychedelic mushroom reached USD 1.93 billion in 2022 and is set to expand at over 10.7% CAGR from 2023 to 2032, led by the ongoing research to discover the potential therapeutic benefits.
The psilocybe product segment generated USD 1.70 billion in revenue in 2022, attributed to ongoing research initiatives along with the growing demand for alternative and holistic approaches to healthcare.
Asia Pacific market is projected to witness 10.1% CAGR through 2032, owing to the growing awareness and acceptance of the potential therapeutic benefits of psychedelics in the region.
Some of the leading psychedelic mushroom companies include Field Trip Health, Atai Life Sciences, Cybin Inc., Mydecine Innovations Group, Revive Therapeutics, and Numinus Wellness.